Literature DB >> 21442272

Long-term administration of cod liver oil ameliorates cognitive impairment induced by chronic stress in rats.

Emil Trofimiuk1, Jan J Braszko.   

Abstract

Cod liver oil (CLO) is a rich source of omega-3 fatty acids (FA), especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The existing data suggest that EPA and DHA are the active agents of fish oil. In this study, we tested a hypothesis that the active constituents of CLO alleviate the negative impact of prolonged restraint stress on cognitive functions of male Wistar rats. Specifically, we attempted to characterize the preventive action of long-lasting treatment with CLO [0.375 ml/100 g body weight (equivalent to a dose of 300 mg/kg DHA and 225 mg/kg EPA), p.o. for 21 days] against an impairment caused by chronic restraint stress (2 h daily for 21 days) on recall as tested in a passive avoidance situation and on the spatial reference and working memory tested in a Barnes maze as well as on locomotor activity and anxiety behavior tested respectively in an open field and elevated plus-maze. We found that CLO administration statistically significantly (p < 0.01, both) prevented the deleterious effects of chronic restraint stress on recall and the spatial memory.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442272     DOI: 10.1007/s11745-011-3551-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  37 in total

Review 1.  Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition.

Authors:  Ype Elgersma; J David Sweatt; K Peter Giese
Journal:  J Neurosci       Date:  2004-09-29       Impact factor: 6.167

Review 2.  A critical review of chronic stress effects on spatial learning and memory.

Authors:  Cheryl D Conrad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-10       Impact factor: 5.067

3.  Regional membrane phospholipid alterations in Alzheimer's disease.

Authors:  M R Prasad; M A Lovell; M Yatin; H Dhillon; W R Markesbery
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

4.  Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet.

Authors:  S Delion; S Chalon; D Guilloteau; B Lejeune; J C Besnard; G Durand
Journal:  J Lipid Res       Date:  1997-04       Impact factor: 5.922

5.  Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus.

Authors:  Yoko Tanabe; Michio Hashimoto; Kozo Sugioka; Megumi Maruyama; Yoshimi Fujii; Rika Hagiwara; Toshiko Hara; Shahdat Md Hossain; Osamu Shido
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-10       Impact factor: 2.557

Review 6.  The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants.

Authors:  M A Crawford; I Golfetto; K Ghebremeskel; Y Min; T Moodley; L Poston; A Phylactos; S Cunnane; W Schmidt
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

7.  Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins.

Authors:  Danuza Ferrari; Roberta M Cysneiros; Carla A Scorza; Ricardo M Arida; Esper A Cavalheiro; Antonio-Carlos G de Almeida; Fulvio A Scorza
Journal:  Epilepsy Behav       Date:  2008-03-04       Impact factor: 2.937

Review 8.  The importance of the ratio of omega-6/omega-3 essential fatty acids.

Authors:  A P Simopoulos
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

9.  Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex.

Authors:  M Nishikawa; S Kimura; N Akaike
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

Review 10.  Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor.

Authors:  Nicolas G Bazan
Journal:  J Lipid Res       Date:  2003-09-16       Impact factor: 5.922

View more
  7 in total

1.  Candesartan prevents impairment of recall caused by repeated stress in rats.

Authors:  Jan Józef Braszko; Dominik Wincewicz; Piotr Jakubów
Journal:  Psychopharmacology (Berl)       Date:  2012-08-14       Impact factor: 4.530

2.  Cod liver oil: a potential protective supplement for human glaucoma.

Authors:  Wen-Bin Huang; Qian Fan; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

3.  Consumption of a high n-3 polyunsaturated fatty acid diet during gradual mild physiological stress in rats.

Authors:  K M Appleton; A J Grippo; T G Beltz; A K Johnson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-12-04       Impact factor: 4.006

Review 4.  Dietary supplements in the management of hypertension and diabetes - a review.

Authors:  Anthony Jide Afolayan; Olubunmi Abosede Wintola
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

Review 5.  N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence.

Authors:  Beth Levant
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-06       Impact factor: 4.388

Review 6.  Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Authors:  Christian Knöchel; Martin Voss; Florian Grüter; Gilberto S Alves; Silke Matura; Beate Sepanski; Michael Stäblein; Sofia Wenzler; David Prvulovic; André F Carvalho; Viola Oertel-Knöchel
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 7.  Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration.

Authors:  Kinga Gawel; Ewa Gibula; Marta Marszalek-Grabska; Joanna Filarowska; Jolanta H Kotlinska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-23       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.